Endoscopic Raman spectroscopy enables objective diagnosis of dysplasia in Barrett's esophagus

Gastrointest Endosc. 2014 Jan;79(1):37-45. doi: 10.1016/j.gie.2013.05.028. Epub 2013 Jul 22.

Abstract

Background: Early detection and targeted endoscopic resection of Barrett's esophagus-associated high-grade dysplasia (HGD) can prevent progression to invasive esophageal malignancy. Raman spectroscopy, a highly sophisticated analytical technique, has been translated into an endoscopic tool to facilitate rapid, objective diagnosis of dysplasia in the esophagus.

Objective: To evaluate the ability of endoscopic Raman spectroscopy (ERS) to objectively detect esophageal HGD and adenocarcinoma.

Design: A total of 798 one-second spectra were measured from 673 ex vivo esophageal tissue samples, collected from patients with Barrett's esophagus by using a novel endoscopic Raman probe. Spectra were correlated with consensus histopathology. Multivariate analysis was used to evaluate the classification accuracy of ERS ex vivo.

Setting: Probe measurements were conducted in the laboratory. Tissue specimens were collected from the operating theatre and endoscopy unit.

Patients: Tissue from 62 patients was included in the study.

Interventions: Endoscopic biopsy/resection or esophagectomy was performed where indicated clinically.

Main outcome measurement: Diagnostic performance of ERS for detection of HGD and esophageal adenocarcinoma.

Results: ERS demonstrated a sensitivity of 86% and a specificity of 88% for detecting HGD and adenocarcinoma. The ability to grade dysplasia and differentiate intestinal metaplasia from nonintestinal metaplasia columnar-lined esophagus was also demonstrated. Diagnostic classification was based on objective measurement of the biochemical profile of different tissue types. The potential for combination ERS and narrow-band imaging was also demonstrated.

Limitations: Measurements were taken from ex vivo tissue.

Conclusion: ERS enables rapid, accurate, objective diagnosis of superficial esophageal disease (metaplasia, dysplasia, intramucosal cancer) in clinically applicable time scales.

Keywords: ER; ERS; HGD; IM; LGD; NBI; NDBE; PC; RS; Raman spectroscopy; WLE; endoscopic Raman spectroscopy; endoscopic resection; high-grade dysplasia; intestinal metaplasia; low-grade dysplasia; narrow-band imaging; nondysplastic Barrett's esophagus; principal component; white light endoscopy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / chemistry*
  • Adenocarcinoma / pathology*
  • Barrett Esophagus / pathology*
  • Biopsy
  • Esophageal Neoplasms / chemistry*
  • Esophageal Neoplasms / pathology*
  • Esophagectomy
  • Esophagoscopy*
  • Esophagus / chemistry
  • Esophagus / pathology*
  • Humans
  • Metaplasia / pathology
  • Narrow Band Imaging
  • Sensitivity and Specificity
  • Spectrum Analysis, Raman*